Aflac stock: Piper Sandler raises target to 143 US dollars

Published on 11/10/2026 at 16:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aflac stock gains a fresh bullish signal as Piper Sandler raises its target after the insurer's mixed third-quarter results. Analyst views remain divided.

What changed for investors

Piper Sandler raised its price target and kept an Overweight rating after Aflac's third-quarter results.
Mizuho also lifted its target, but retained an Underperform rating, leaving analyst views divided.
Stronger adjusted earnings and capital flexibility contrast with weaker revenue and softer premium-equivalent trends.

AFLAC Inc., US0010551028, Illustration mit AI erstellt.

Piper Sandler raised its price target for Aflac from 138 US dollars to 143 US dollars after the insurer's third-quarter results, while keeping an Overweight rating on the shares. MarketBeat said the revision followed the quarterly release and reflected the analyst's optimistic view of Aflac's outlook.

Analyst signals remain split

The move adds a bullish counterpoint to Mizuho's decision to raise its target to 112 US dollars while retaining an Underperform rating. Mizuho also lifted its fiscal 2026 earnings estimate by 9 percent to 7.70 US dollars per share and increased its fiscal 2027 and 2028 estimates to 7.65 and 8.05 US dollars.

Aflac's third-quarter picture remains mixed. Normalized earnings per share reached 1.80 US dollars, while adjusted earnings per diluted share came to 2.43 US dollars after actuarial assumption changes. Revenue was 3.27 billion US dollars, below the 4.11 billion US dollar consensus cited in the latest Aflac coverage.

Capital and demand in focus

Portfolio-switching transactions have added more than 80 million US dollars in annualized net investment income so far this year. A planned cession of about 500 billion yen of cancer reserves to Aflac Re Bermuda is expected to release roughly 1 billion US dollars of capital, potentially supporting shareholder returns and future investment.

The operating backdrop remains less uniform. Japan's new premium equivalents continue to shrink, while growth in the United States remains in the lower half of Aflac's target range. That combination leaves investors weighing improved assumptions and capital flexibility against uneven demand.

Aflac stock traded at 112.10 euros on Lang & Schwarz at 16:09 CET on Tuesday, November 10, 2026.